Eligard® 45
Brand Name: Eligard® 45 mg
Composition: Leuprolide Acetate for Injectable Suspension
Manufacturer: Emcure®
Product Description
Medical Info
Eligard® 45 mg is a sterile, subcutaneous injection formulated as an injectable suspension containing Leuprolide Acetate. Designed for long-term therapeutic management, this specific strength is administered once every 6 months. As a prescription-only ($R_X$) medication, it must be properly reconstituted before use by a healthcare professional and strictly stored under refrigerated conditions between 2°C to 8°C (36°F to 46°F) to maintain its stability and efficacy. The product is manufactured and distributed by Emcure Pharmaceuticals, ensuring adherence to stringent clinical and sterile manufacturing standards.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
